FII Holdings

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1358.9526.7 (+2 %)
PREV CLOSE ( ) 1332.25
OPEN PRICE ( ) 1349.45
BID PRICE (QTY) 1358.60 (18)
OFFER PRICE (QTY) 1361.00 (17)
VOLUME 5515
TODAY'S LOW / HIGH ( )1324.75 1373.85
52 WK LOW / HIGH ( )647.1 1617.8
NSE1361.1525.15 (+1.88 %)
PREV CLOSE( ) 1336.00
OPEN PRICE ( ) 1339.00
BID PRICE (QTY) 1359.75 (8)
OFFER PRICE (QTY) 1361.25 (2)
VOLUME 76763
TODAY'S LOW / HIGH( ) 1325.00 1372.70
52 WK LOW / HIGH ( )646.8 1619.05
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.